• UGI USER
  • Feb 08, 2024
  • 17 Likes
  • 0 Comments

INDIGENOUS CAR-T CELL THERAPY

Focus: CAR-T Cell Therapy

How CAR-T Cell Therapy Works?

Source: National Cancer Institute

About CAR-T Cell Therapy:

  • Jointly developed by ImmunoACT, IIT Bombay, and Tata Memorial Hospital.
  • Administered to 15 patients in India, resulting in three successful cancer remissions.
  • Genetically reprograms the immune system to combat B-cell cancers.
  • Affordable option in India compared to international costs.
  • Targets B-cell lymphomas, especially beneficial for relapsed or refractory cases.
About B-cell lymphomas

·   B-cell lymphomas are cancers that originate from abnormal B lymphocytes, a type of white blood cell.

·   They affect the lymphatic system and can manifest in various forms, including Hodgkin and non-Hodgkin lymphoma.